NYSE
STE
Last Price
US $208.73
KEY FIGURES
MKT CAP
$20.3B
EPS
TTM
$7.98
PEG
TTM
0.98x
P/E
TTM
26.14x
P/S
TTM
3.45x
YIELD
1.21%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
9.53%
Return on equity
ROIC: 7.21%
Valuation History
36.6X
Price to Earnings
EV/EBITDA: 18.0X
Cash flow
Profit margin
13.82%
(FY vs FY)
EBITDA Y/Y
15.55%
(FY vs FY)
Cash flow Y/Y
16.64%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $208.73
-42.50%
Default assumptions
EBITDA Multiple
Fair Value
Market $208.73
-63.48%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
STERIS plc cash flow to debt ratio of 64.27% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial stability - Healthy cash flow growth.
STERIS plc's free cash flow has increased 24.99% from $778.00M last year to $972.40M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
STERIS plc's debt to equity ratio is 0.29, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
STERIS plc's debt has decreased relative to shareholder equity from 0.33 last year to 0.29 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
STERIS plc has a net debt to EBITDA ratio of 1.03x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
STERIS plc's interest coverage ratio of 18.15 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
STERIS plc's profit margin has increased (17.08%) in the last year from 11.26% to 13.18%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
STERIS plc's short-term assets of $2.39G exceed its short-term liabilities of $1.15G
Increasing performance - ROA.
STERIS plc's return on assets of 7.29% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
STERIS plc's return on equity of 11.05%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
STERIS plc's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
STERIS plc had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
STERIS plc has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
STERIS plc has a free cash flow yield of 4.78%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
STERIS plc's yearly earnings has increased 27.73% since last year from $614.64M to $785.10M, signaling increasing performance
Increasing performance - Healthy revenue growth.
STERIS plc's yearly revenue has increased 8.73% since last year from $5.46G to $5.94G, signaling increasing performance
Increasing performance - ROIC.
ROIC 8.47% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
STERIS plc's 3-year revenue CAGR of 9.38% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
STERIS plc had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
STERIS plc had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
STERIS plc is overvalued relative to its fair value price of 120.01 based on Discounted Cash Flow model
Overvalued - Earnings yield.
STERIS plc has an earnings yield of 3.82%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
STERIS plc is overvalued relative to its fair value price of 76.22 based on EBITDA multiple model
Undervalued - EV/EBITDA.
STERIS plc has an EV/EBITDA ratio of 13.79x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
STERIS plc has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
STERIS plc has a price-to-book ratio of 2.84x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
STERIS plc has a price-to-sales ratio of 3.45x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue